(Q37987723)

26 August 2017

T-cell-receptor-like antibodies - generation, function and applications (English)

1 reference

26 August 2017

1 reference

Rony Dahan

1

0 references

author name string

Yoram Reiter

series ordinal

2

1 reference

26 August 2017

24 February 2012

1 reference

Expert Reviews in Molecular Medicine

26 August 2017

1 reference

26 August 2017

14

1 reference

26 August 2017

e6

1 reference

Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing

26 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

A novel postpriming regulatory check point of effector/memory T cells dictated through antigen density threshold-dependent anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Therapeutic antibodies: Discovery and development using the ProteOn XPR36 biosensor interaction array system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA-A2/Mage3 complex density using a high-affinity TCR like monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Antibodies and lentiviruses that specifically recognize a T cell epitope derived from HIV-1 Nef protein and presented by HLA-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Recognition of insulin on MHC-class-II-expressing L929 cells by antibody and T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Rational development of high-affinity T-cell receptor-like antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies i

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Selecting and screening recombinant antibody libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Trastuzumab-mediated antibody-dependent cellular cytotoxicity against esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Viral effects on antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Immunological memory to viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Design and evaluation of antigen-specific vaccination strategies against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Monoclonal T-cell receptors: new reagents for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Successful treatment of melanoma brain metastases with adoptive cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Assessing vaccine potency using TCRmimic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Dendritic cell-based immunotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Therapeutic dendritic cell vaccination of patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Therapeutic potential of anticancer immunotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

A systematic review of treatment guidelines for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Monoclonal antibodies: versatile platforms for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Short communication: generation of recombinant monoclonal antibodies against an immunodominant HLA-A*2402-restricted HIV type 1 CTL epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

MHC class I-presented lung cancer-associated tumor antigens identified by immunoproteomics analysis are targets for cancer-specific T cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

A listing of human tumor antigens recognized by T cells: March 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

Isolation of high affinity human antibodies directly from large synthetic repertoires.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

7 January 2021

IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

7 January 2021

Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

7 January 2021

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

7 January 2021

Functional expression of chimeric receptor genes in human T cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

7 January 2021

Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

7 January 2021

Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1017%2FERM.2012.2

7 January 2021

Identifiers

DOI

10.1017/ERM.2012.2

1 reference

26 August 2017

1 reference

PubMed ID

22361332